Publication | Open Access
microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer
119
Citations
27
References
2013
Year
Our data suggest that oncogenic miR-183 may be useful as a new PC biomarker and that inhibition of miR-183 expression may be therapeutically beneficial as a PC treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1